AI assistant
Sending…
NATIONAL RESEARCH CORP — Director's Dealing 2009
May 12, 2009
33341_dirs_2009-05-12_2452826f-7533-46b1-a2e4-148e41a9e792.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NATIONAL RESEARCH CORP (NRCI)
CIK: 0000070487
Period of Report: 2009-05-08
Reporting Person: MARTIN JOANN M (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-05-08 | Director Stock Option (Right to Buy) | $27.23 | A | 12000 | Acquired | 2019-05-08 | Common Stock (12000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2500 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Director Stock Option (Right to Buy) | $7.6 | 2012-05-01 | Common Stock (1000) | 1000 | Direct |
| Director Stock Option (Right to Buy) | $9.6 | 2013-05-01 | Common Stock (1000) | 1000 | Direct |
| Director Stock Option (Right to Buy) | $16.94 | 2014-05-06 | Common Stock (1000) | 1000 | Direct |
| Director Stock Option (Right to Buy) | $16.05 | 2014-05-21 | Common Stock (11000) | 11000 | Direct |
| Director Stock Option (Right to Buy) | $14.2 | 2015-05-05 | Common Stock (12000) | 12000 | Direct |
| Director Stock Option (Right to Buy) | $22.61 | 2016-05-04 | Common Stock (12000) | 12000 | Direct |
| Director Stock Option (Right to Buy) | $25.05 | 2017-05-03 | Common Stock (12000) | 12000 | Direct |
| Director Stock Option (Right to Buy) | $29.87 | 2018-05-02 | Common Stock (12000) | 12000 | Direct |
Footnotes
F1: Director stock option was granted subject to shareholder approval at the 2010 annual meeting of an amendment to the National Research Corporation 2004 Non-Employee Director Stock Plan.
More from NATIONAL RESEARCH CORP
Regulatory Filings
2026
May 13
Annual Report
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
Apr 28
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 20